We are live on ! Find out more
BCM

Bronte Capital Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 47.99%
This Fund
S&P 500
This Quarter Est. Return
+9.02%
1 Year Est. Return
+47.99%
3 Year Est. Return
+112.22%
5 Year Est. Return
+138.3%
10 Year Est. Return
AUM
$1.23B
AUM Growth
+$106M
Cap. Flow
-$1.52M
Cap. Flow %
-0.12%
Top 10 Hldgs %
71.96%
Holding
32
New
2
Increased
10
Reduced
18
Closed
2

Sector Composition

Rank Sector Weight
1 Financials 26.24%
2 Communication Services 19.28%
3 Healthcare 12.87%
4 Consumer Discretionary 10.45%
5 Consumer Staples 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$4.36T
$160M 13.08%
1,061,577
-30,910
-3% -$4.42M
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.1T
$152M 12.4%
361,240
-53,394
-13% -$21M
REGN icon
3
Regeneron Pharmaceuticals
REGN
$78.5B
$140M 11.4%
145,073
-348
-0.2% -$331K
IBKR icon
4
Interactive Brokers
IBKR
$39.2B
$94.1M 7.68%
3,369,700
+24,924
+0.7% +$621K
AMZN icon
5
Amazon
AMZN
$2.92T
$71.9M 5.87%
398,719
-2,757
-0.7% -$460K
PINS icon
6
Pinterest
PINS
$13.4B
$48.7M 3.98%
1,404,998
-9,698
-0.7% -$353K
HIBB
7
DELISTED
Hibbett, Inc. Common Stock
HIBB
$46.8M 3.82%
609,232
+5,021
+0.8% +$360K
PM icon
8
Philip Morris
PM
$297B
$44.1M 3.6%
481,504
+55,851
+13% +$5.15M
FCNCA icon
9
First Citizens BancShares
FCNCA
$24.9B
$43M 3.51%
26,280
+190
+0.7% +$286K
IBB icon
10
iShares Biotechnology ETF
IBB
$9.34B
$38.9M 3.17%
283,420
+1,892
+0.7% +$258K
IJR icon
11
iShares Core S&P Small-Cap ETF
IJR
$109B
$35.7M 2.91%
+322,789
New +$34.3M
RAMP icon
12
LiveRamp
RAMP
$2.3B
$35.7M 2.91%
322,789
+261,899
+430% +$9.63M
CTVA icon
13
Corteva
CTVA
$52.6B
$35.6M 2.91%
617,207
+4,568
+0.7% +$236K
DFS
14
DELISTED
Discover Financial Services
DFS
$32.5M 2.65%
+248,059
New +$28.4M
HLF icon
15
Herbalife
HLF
$1.29B
$28.2M 2.3%
2,805,253
-297,464
-10% -$3.2M
MTCH icon
16
Match Group
MTCH
$9.19B
$27.3M 2.22%
751,205
-528
-0.1% -$19.1K
IWM icon
17
CALL
iShares Russell 2000 ETF
IWM
$79.8B
$24.2M 1.97%
89,300
-110,700
-55% -$22.1M
GHC icon
18
Graham Holdings Company
GHC
$5.1B
$17.2M 1.4%
22,405
-3
-0% -$2.15K
BBWI icon
19
Bath & Body Works
BBWI
$4.06B
$9.36M 0.76%
187,174
-2,341
-1% -$105K
VRTX icon
20
Vertex Pharmaceuticals
VRTX
$121B
$8.62M 0.7%
20,617
-143
-0.7% -$60.5K
BNTX icon
21
BioNTech
BNTX
$22.9B
$7.42M 0.61%
80,406
+57,042
+244% +$5.47M
SQM icon
22
Sociedad Química y Minera de Chile
SQM
$19.2B
$7.12M 0.58%
144,824
-21,795
-13% -$1.02M
MDLZ icon
23
Mondelez International
MDLZ
$79.5B
$4.67M 0.38%
66,780
-149
-0.2% -$10.9K
GIS icon
24
General Mills
GIS
$19.1B
$3.08M 0.25%
44,086
-55,090
-56% -$3.59M
RSKD icon
25
Riskified
RSKD
$694M
$2.72M 0.22%
502,662
-7,492
-1% -$35.6K

Similar funds

Bronte Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Bronte Capital Management held 32 positions worth $1.23B, up 9.4% from $1.12B the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Bronte Capital Management's Q1 2024 filing shows 2 new, 10 increased, 18 reduced and 2 closed positions. Its largest new stake was iShares Core S&P Small-Cap ETF: 322,789 shares worth $35.7M. The largest sale was Berkshire Hathaway Class B, an estimated $21M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 23% a quarter earlier, followed by Communication Services and Healthcare.

  • Bronte Capital Management's largest Q1 2024 buy was iShares Core S&P Small-Cap ETF: 322,789 shares worth $35.7M.
  • Bronte Capital Management added most to LiveRamp in Q1 2024, an estimated $9.63M increase.
  • Bronte Capital Management's biggest Q1 2024 reduction was Berkshire Hathaway Class B, cutting an estimated $21M.
  • Bronte Capital Management fully exited Alphabet (Google) Class C in Q1 2024, selling an estimated $9.77M.
  • Bronte Capital Management's ten largest holdings make up 72% of its $1.23B portfolio in Q1 2024.
  • Bronte Capital Management opened 2 new positions and closed 2 in Q1 2024.
  • Bronte Capital Management's portfolio value rose 9.4% quarter-over-quarter to $1.23B.

Based on Bronte Capital Management's 13F filing for Q1 2024, filed 13 May 2024.